Oncology & Cancer

Antineoplastic agents associated with thyroid dysfunction

Antineoplastic agents such as immunotherapies and targeted therapies that specifically target signaling pathways in cancer cells are associated with thyroid dysfunction in 20%-50% of cancer patients taking them, which can ...

Oncology & Cancer

Key growth factor identified in T cell leukemia

Blocking a growth factor receptor cripples cancer growth in a form of T cell leukemia, according to a study published online on August 1 in the Journal of Experimental Medicine.

Medical research

Once blamed for aging, ROS molecules may actually extend life

(Medical Xpress) -- In a new study, Yale University researchers have identified a pathway by which reactive oxygen species (ROS) molecules, which are usually implicated in the aging process due to their damage to DNA, can ...

page 11 from 12